At a September 10, 2026 webinar, Amanda Mohr of the Center for Forensic Science Research and Education showed that officers recorded dilated pupils in room light in only 24 of 102 drivers whose blood showed stimulants and no other drug category, even though the officers had correctly called every one of them as a stimulant user. Dilated pupils are what the drug evaluation chart says a stimulant should produce.
The overall match rates in that presentation favor the program, and they come first below. An officer’s report in a Tampa Bay drug DUI lists individual signs, though, and this data shows how often each sign was actually there when the drug was.
What the Study Compared
The officers in this data were trained under the Drug Recognition Expert (DRE) program, which teaches a 12-step evaluation, including a breath test, eye exams, balance tests, vital signs, a dark-room pupil check and an interview, that ends with the officer naming one or more drug categories. The program lists the officer’s opinion before the toxicology in its sequence. The presentation, titled “Trust the Signs? Connecting DRE Evaluations with Toxicology,” matched those opinions to blood results tested at NMS Labs, with the evaluations coded by the Institute for Traffic Safety Management and Research. The slides credit funding from Responsibility.org and support from the Governors Highway Safety Association. It was a webinar, not a peer-reviewed paper.
The Numbers That Favor the Program
When the blood showed only one drug category, the officer’s opinion named that kind most of the time. For cannabis alone, the opinion included cannabis in 280 of 297 cases, or 94%. For stimulants alone it was 102 of 119, or 86%. For narcotic painkillers alone it was 39 of 46, or 85%. The presentation’s conclusion is that agreement between the officers’ opinions and the lab “remained strong.”
The picture changes once other drugs are in the blood, which the presentation says is common. Across every case where the lab found a stimulant, alone or with other drugs, the officer’s opinion left stimulants out in 153 of 500. For narcotic painkillers it was 102 of 356, and for cannabis 100 of 605.
No Drug-Negative Cases in the Data
Every case in this data had a positive blood test. The slides list the limits plainly: there was “no control data,” evaluations where the blood came back negative for drugs aren’t part of the analysis, and the time between the evaluation and the blood draw was unknown. So the 94% answers one question: when cannabis was in the blood, how often did the officer say cannabis? It doesn’t answer the question a jury cares about, which is how often an officer calls a drug that isn’t there, or calls impairment in a person who isn’t impaired. The slides report no false-positive rate, and leaving out the drug-negative evaluations means one can’t be figured from this data.
Presence isn’t impairment, either. A positive blood test alone doesn’t show the drug was affecting the driver at the time of the stop. My page on why a drug in your blood isn’t proof of impairment covers that gap.
The Signs the Report Lists
The evaluation runs on a chart, often called the matrix, that lists what each drug category is supposed to do to the eyes, the pulse, blood pressure, body temperature and muscle tone. An officer’s report checks off what was seen and then names the category that fits. The presentation compared what officers recorded against what the chart predicts, in single-category cases where the blood confirmed the drug and the officer had named the right category. A drug evaluation is an officer’s opinion, and an opinion isn’t a measurement. This data lets you test that opinion against the chart it claims to follow.
For the 102 stimulant-only drivers the officers called correctly, the chart predicts dilated pupils, a raised pulse, raised blood pressure, raised body temperature and rigid muscle tone. In room light, one of the three lighting conditions in the exam, officers recorded dilated pupils in 24 of the 102 and an elevated body temperature in 4 of 102. Rigid muscle tone appeared in 56%. Blood pressure did better, with the top (systolic) number above the normal range in 72%.
For the 39 narcotic-only drivers the officers called correctly, the chart predicts constricted pupils, a lower pulse, lower blood pressure, lower body temperature and flaccid muscle tone. In room light, officers recorded constricted pupils in 10 of the 39 and a lowered body temperature in 9 of 39. Flaccid muscle tone was the most common match, at 27 of 39.
The presenters say signs that point to no particular drug, such as bloodshot eyes and tremors, showed up often, while some of the category signs were “less consistent,” and they give the reasons: drug effects vary, people respond differently, drugs get mixed and timing matters. Their conclusion is that the evaluation’s value comes from the whole picture and not from “any single observation.” That’s the State’s answer. By the presenters’ own account, then, a single sign in an officer’s report shouldn’t be read on its own.
Reading Your Evaluation Against the Chart
A drug evaluation in Florida comes in as an officer’s opinion, and under section 90.702 of Florida’s evidence code the judge has to screen whether it rests on a reliable method reliably applied. The signs in your report are the evidence the method rests on. When the report leans on pupils or body temperature to name a stimulant or a narcotic, this data shows the predicted room-light pupil and temperature findings weren’t recorded in most of the confirmed cases, even ones the officer got right. When the report fits the chart neatly, the next question is whether the chart was filled in before or after the officer had a theory, which my page on attacking DRE reliability walks through.
I ask for the officer’s full evaluation form, called the face sheet, the officer’s training log and the record of their past calls against toxicology, the blood draw time, and the lab report. My drugged driving defense page covers how I handle a drug DUI, and the drug categories and matrix page shows the full chart.
Further Reading
The sources behind this post.
- “Trust the Signs? Connecting DRE Evaluations with Toxicology,” Center for Forensic Science Research and Education webinar (Sept. 10, 2026)
- Section 90.702, Florida Statutes
This post is general information about the law, not legal advice, and it does not create an attorney-client relationship. Past results do not guarantee a similar outcome. The law discussed is section 90.702, Florida Statutes (2026). The data discussed is from A. Mohr, “Trust the Signs? Connecting DRE Evaluations with Toxicology,” Center for Forensic Science Research and Education webinar (Sept. 10, 2026), which was not peer reviewed.

